
How pharmacists can improve their relations with nurses in nursing homes

florida pharmacists react to state's medicaid audits

What's behind the current rampant drug shortages? Pharmacists want to know

NHIN offers test to help pharmacies, PBMs, and software vendors transition to NCPDP's version 5.1 claim standard

cutting back on medications in nursing homes

Pharmacies acquire Rxs at AWP minus 22%, report by HHS IG states

NACDS and NCPA launch SureScript to compete with RxHub

How to code claims

ASHP pushes for a medication safety officer in every hospital

NACDS and NCPA launch SureScript to compete with RxHub

Should pharmacists follow Arizona's example by not seeking or giving information about patients suspected of being drug seekers?

Medication errors have become the No. 1 priority in hospitals now that JCAHO's patient safety standards went into effect on July 1

Pharmacists are still at a premium across the country, exclusive survey finds

cvs and walgreens sales slowing


R.Ph. wins historic court case requiring health plans to cover birth control

Newly united pharmacy searches for new payment model as Medicare drug benefit looms

nacds patners with america's promise alliance for youth program

Rising health costs are driving managed care organizations to add OTCs to their drug benefit

A task force has recommended that the National Association of Boards of Pharmacy's take actions to combat drug diversion through institutional outlets.

Synthroid needs proof to stay: FDA

Some payers are now moving away from external PBMs to control their drug cost. They are considering setting up in-house PBMs or not using a PBM at all.

USP program gets legal protection

ASHP and ACCP are seeking federal provider status for pharmacists so they can bill Medicare for cognitive services.

JCAHO issues new standards for hospitals to meet

Health Resources provides chains with custom newsletter

AMCP launches standardized template to help pharmacists obtain clinical and economic data on new drugs from manufacturers for formulary consideration

Pharmacogenomics will lead to predictable patient outcomes, so drug companies will change the way they price, market, and distribute genomically produced drugs

Drug company executives think pharmacists are a growing force to be reckoned with, an exclusive survey finds